33 Participants Needed

Gastrostomy Tube vs Stent for Esophageal Cancer

DL
SS
DL
Overseen ByDeb Lewis, BSc
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The main goal of this trial is to assess whether it's feasible to conduct a larger, full-scale study comparing the use of gastrostomy (g-tubes) and stents in patients with unresectable cancer of the stomach and/or esophagus, and to evaluate their impact on patients' quality of life. Additional objectives include examining the rates of complications, the need for additional treatments, and the total number of hospital days over a three-month period.

Research Team

RN

Rahul Nayak, MD MSc

Principal Investigator

London Health Sciences Centre

Eligibility Criteria

This trial is for patients with inoperable esophageal or stomach cancer, specifically at the gastroesophageal junction (GEJ). It's focused on those who haven't had previous treatments that would interfere with the study. Details about specific inclusion and exclusion criteria are not provided.

Inclusion Criteria

I am 18 or older with advanced cancer in my stomach or esophagus that cannot be surgically removed.

Exclusion Criteria

Prior Esophageal Stent or gastrostomy tube
I am under 18 years old.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either a gastrostomy tube or esophageal stent for palliation

3 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Gastrostomy Tube
  • Self Expanding Metal Esophageal Stent
Trial Overview The trial is testing two methods to help manage symptoms: a gastrostomy tube (g-tube) which provides nutrition directly to the stomach, and a self-expanding metal stent that keeps the esophagus open. The goal is to see which method improves quality of life and requires fewer hospital visits over three months.
Participant Groups
2Treatment groups
Active Control
Group I: Gastrostomy TubeActive Control1 Intervention
Gastrostomy Tube insertion for palliation
Group II: Esophageal StentActive Control1 Intervention
Self Expanding Esophageal stent insertion for palliation

Find a Clinic Near You

Who Is Running the Clinical Trial?

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Lead Sponsor

Trials
678
Recruited
421,000+

London Health Sciences Centre OR Lawson Research Institute of St. Joseph's

Lead Sponsor

Trials
668
Recruited
424,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security